{"id":99682,"date":"2004-10-22T06:00:00","date_gmt":"2004-10-22T04:00:00","guid":{"rendered":"https:\/\/mediarun.com\/index.php\/news-posts\/przetargi-w-us-pharmacia\/"},"modified":"2004-10-22T06:00:00","modified_gmt":"2004-10-22T04:00:00","slug":"przetargi-w-us-pharmacia","status":"publish","type":"post","link":"https:\/\/mediarun.com\/pl\/marketing\/atl\/przetargi-w-us-pharmacia.html","title":{"rendered":"Przetargi w US Pharmacia"},"content":{"rendered":"<p><P>&#8211; Celem obecnych przetarg\u00f3w jest wy\u0142onienie, dla najwa\u017cniejszych grup biznesowych US Pharmacia, strategicznych partner\u00f3w full serwisowych z kt\u00f3rymi firma chce wsp\u00f3\u0142pracowa\u0107 przez d\u0142u\u017cszy okres czasu. Decyzja ta zapad\u0142a po analizie bie\u017c\u0105cych potrzeb rozwojowych biznesu USP w Polsce, ale tak\u017ce w oparciu o plany budowy biznesu wynikaj\u0105ce z planu wieloletniego &#8211; m\u00f3wi Andrzej Schonert, Dyrektor Marketingu US Pharmacia.<\/P><br \/>\n<P>Przetarg Kategorii Lek\u00f3w Gastrycznych do kt\u00f3rej nale\u017c\u0105 marki: Manti, Stoperan, Xenna<\/P><br \/>\n<P>Zakres przetargu: obs\u0142uga strategiczna ATL i BTL<BR>Zaproszonych do udzia\u0142u : 5 agencji <BR>Og\u0142oszenie wynik\u00f3w: do 22.10.2004<\/P><br \/>\n<P><BR>Przetarg Kategorii VMS i Lek\u00f3w Naturalnych do kt\u00f3rej nale\u017cy marka VIGOR i NATURAPIA<\/P><br \/>\n<P>Zakres przetargu: obs\u0142uga strategiczna ATL i BTL dla obu kategorii<BR>Zaproszonych do przetargu: 5 agencji <BR>Og\u0142oszenie wynik\u00f3w: do ko\u0144ca Pa\u017adziernika<\/P><\/p>\n","protected":false},"excerpt":{"rendered":"W US Pharmacia, po wygranym przez Red 8 przetargu na obs\u0142ug\u0119 ATL marki Gripex, kt\u00f3ra nale\u017cy do kategorii przeciewprzezi\u0119bieniowej, obecnie trwaj\u0105 jeszcze dwa inne konkursy.","protected":false},"author":1,"featured_media":99683,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"csco_display_header_overlay":false,"csco_singular_sidebar":"","csco_page_header_type":"","csco_page_load_nextpost":"","csco_post_video_location":[],"csco_post_video_location_hash":"","csco_post_video_url":"","csco_post_video_bg_start_time":0,"csco_post_video_bg_end_time":0,"footnotes":""},"categories":[9642],"tags":[],"class_list":{"0":"post-99682","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-atl","8":"cs-entry","9":"cs-video-wrap"},"_links":{"self":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts\/99682","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/comments?post=99682"}],"version-history":[{"count":0,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts\/99682\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/media\/99683"}],"wp:attachment":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/media?parent=99682"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/categories?post=99682"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/tags?post=99682"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}